Prospective study on nanoparticle albumin-bound paclitaxel in advanced breast cancer: clinical results and biological observations in taxane-pretreated patientsAlessandra Fabi, Laura Iacorossi, Marcella Mottolese et al.|Drug Design Development and Therapy|2015Cited by 29
Epidermal growth factor receptor gene copy number may predict lapatinib sensitivity in HER2-positive metastatic breast cancerAlessandra Fabi, Marcella Mottolese, Roberta Merola et al.|Expert Opinion on Pharmacotherapy|2013Cited by 17
Nanoparticle Albumin-Bound Paclitaxel/Liposomal-Encapsulated Doxorubicin in HER2-Negative Metastatic Breast Cancer PatientsF. Cognetti, G. Ferretti, Paola Malaguti et al.|Future Oncology|2020Cited by 13
Pilot study of capecitabine combined with celecoxib (CapCel) for the treatment of far advanced metastatic breast cancer (MBC) patients (pts)Alessandra Fabi, F. Cognetti, Michele Stanislaw Milella et al.|Journal of Clinical Oncology|2006Cited by 1
Phase I of weekly nab-paclitaxel in combination with weekly liposomal encapsulated doxorubicin as first-line treatment for HER2 negative metastatic breast cancer patients: preliminary resultsAlessandra Fabi, Francesco Cognetti, Paola Malaguti et al.|Annals of Oncology|2015Cited by 0